Genmab Announces Phase 3 EPCORE® FL-1 Clinical Trial Met Dual Primary Endpoints in Patients with Relapsed/Refractory (R/R) Follicular Lymphoma (FL) Company AnnouncementCOPENHAGEN, Denmark; August 7, ...

Genmab Announces Financial Results for the First Half of 2025August 7, 2025 Copenhagen, Denmark; Interim Report for the First Half Ended June 30, 2025HighlightsEpcoritamab advancing to earlier lines ...

Galapagos Creates New Subscription Right Plan Mechelen, Belgium; August 7, 2025, 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) announced today that its  Board of Directors ...

A major breakthrough in surgical embodied intelligence in Robot-Assisted Surgery (RAS) has been achieved in Hong Kong, China.

The global women’s health diagnostics market is set to witness a growth rate of ~7% in the next 5 years. Increasing prevalence of women’s health disorders, growing awareness and government initiatives ...

The chromatography reagents market, projected to grow at a CAGR of ~8%, is expanding due to increasing applications in drug ...

In an era where chronic diseases are reshaping global health priorities, the diabetic retinopathy market stands out as a ...

The global apheresis market is expected to grow at a CAGR of ~8% during the forecast period. The market expansion is driven ...

The global ovarian cancer diagnostics market is set to witness a growth rate of ~6% in the next 5 years. Rising incidence of ...

CET/CESTThe issuer is solely responsible for the content of this announcement.CureVac Announces Resolution of Patent Litigation with Pfizer/BioNTech TÜBINGEN, Germany / BOSTON, USA – August 7/8, 2025 ...

Explores Behemoth Labz GLP‑1 nasal formulation's structural design, analytic insights, and intranasal incretin research relevance in preclinical metabolic ...

LOS ANGELES, CA / ACCESS Newswire / August 7, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, ...